Evidence map›Paper›PMID 17981794›Full record

ArticleInternational immunology2007

The transmembrane tyrosine of micro-heavy chain is required for BCR destabilization and entry of antigen into clathrin-coated vesicles.

Jin Hyang Kim, Jennifer A Rutan, Barbara J Vilen

Open access · bronzeAbstract read
In one paragraph

Article in International immunology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jin Hyang KimDepartment of Microbiology and Immunology and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Jennifer A Rutan
Barbara J Vilen
University of North Carolina at Chapel Hill · US

Funding

Molecular Basis for Overcoming Tolerance to SmR01AI053266 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI VILEN, BARBARA J · 2003 to 2007
$1.6M
NIAID NIH HHS AI53266NIAID NIH HHS R01 AI053266
6 · The paper itself

Abstract

The B cell antigen receptor (BCR) delivers antigen to the endocytic compartment and transduces signals that regulate the stability of the receptor complex. Previous studies showed that BCR-mediated signal transduction dissociates micro-heavy chain (microm) from Ig-alpha/Ig-beta, facilitating the delivery of antigen to clathrin-coated vesicles (CCVs). Herein, we demonstrate that the dissociation of Ig-alpha/Ig-beta from microm requires tyrosine-587 of the microm transmembrane domain. Receptors expressing a mutation at tyrosine-587 (Y587F) transduced signals that were comparable to wild type, yet they failed to dissociate microm from Ig-alpha/Ig-beta. Further, receptors harboring the Y587F mutation failed to associate with CCVs, resulting in diminished antigen in the lysosome-associated membrane protein-1 (LAMP-1(+)) compartment and severely impaired antigen presentation, indicating that endocytosis through CCVs is required for antigen presentation. Thus, the transmembrane tyrosine of mum mediates destabilization of the BCR complex, facilitating antigen processing by promoting the association of antigen with CCVs.

Indexed as

Antigen PresentationAnimalsAntigensB-LymphocytesCell LineClathrin-Coated VesiclesImmunoglobulin Heavy ChainsLysosomal-Associated Membrane Protein 1Lysosomal Membrane ProteinsMiceMicroscopy, Electron, TransmissionMutationReceptors, Antigen, B-CellSignal TransductionTyrosineAntigensImmunoglobulin Heavy ChainsLamp1 protein, mouseLysosomal-Associated Membrane Protein 1Lysosomal Membrane ProteinsReceptors, Antigen, B-CellTyrosine

Identifiers

PMID17981794
PMCPMC3716379
OpenAlexW2121838513

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.